Share Your Voice

Tell the FDA Why New Treatment Options Matter
When promising new cancer treatments are denied approval, the impact is felt far beyond a single diagnosis. Patients with all types of cancer—melanoma, breast, lung, pancreatic, ovarian, and more—are left with fewer chances to survive and fewer ways to fight their disease.
For many living with advanced cancer, standard therapies work for only a time—or not at all. Once those treatments stop working, there are often no good options left. Every new therapy that shows promise represents hope: hope for more time, better quality of life, and the possibility of beating the odds.
Access matters. Many people do not live near major cancer centers or have the means to travel for specialized care or clinical trials. Approving safe, effective treatments can help close this gap, giving more patients the opportunity to benefit—no matter where they live.
The FDA needs to hear from those who understand what is at stake. Share your story. Share how cancer has touched your life, how limited options have affected you or your loved ones, and what access to more treatments would mean.
Your voice can help the FDA understand that more treatment options mean more chances—across all cancers—for survival, for time with loved ones, and for dignity in care.
Share Your Thoughts
When completing the form below, it is okay to use some kind of general identifier such as “Jennifer P., Oregon” or “Stage IV patient, Minnesota”. You can also leave the name field blank and be anonymous.
Tell the FDA Why New Treatment Options Matter
Patient Story